The Peptides Frequently Referenced in the Current Debate Online discussions commonly reference a group of peptides in connection with Category 2 and potential reform
Tirzepatide, a GLP-1/GIP dual agonist, has demonstrated mean body weight reductions of approximately 20.9% over 72 weeks in adults with obesity
These drugs, widely used for weight loss and diabetes management, were associated with cognitive and behavioral health benefits, including reduced risks of addiction, dementia, and neurocognitive disorders
et al., 2024), GLP-1 RAs function as incretin mimetics, stimulating insulin release by pancreatic -cells in a glucose-dependent manner while suppressing glucagon secretion from -cells (Figure 1)
Characterization of lysosomal acid lipase by site-directed mutagenesis and heterologous expression